News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
226 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (28806)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (245)
2 (268)
3 (95)
4 (1)
5 (6)
6 (48)
7 (300)
8 (281)
9 (312)
10 (112)
11 (2)
12 (8)
13 (250)
14 (196)
15 (213)
16 (211)
17 (121)
18 (12)
19 (15)
20 (224)
21 (214)
22 (226)
23 (201)
24 (85)
25 (3)
26 (7)
27 (215)
28 (222)
29 (206)
30 (220)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
ExtriCARE USA Hires Matthew Cranfill As Director Of Clinical Services
ExtriCARE USA, a national medical device company specializing in negative pressure wound therapy distribution, proudly announces the addition of Matthew Cranfill, RN, BSN, WOCN, as Director of Clinical Services.
September 22, 2021
·
2 min read
Pharm Country
Camber Spine Launches SPIRA-P and SPIRA-T Implants for National Distribution
Camber Spine, a leading innovator in spine and medical technologies, has initiated the full national launch of its SPIRA-P Posterior Lumbar Spacer and SPIRA-T Oblique Posterior Lumbar Spacer devices.
September 22, 2021
·
2 min read
Drug Development
INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico
INOVIO (NASDAQ:INO), today announced that it has received authorization from COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios), the national health regulatory agency of Mexico, to conduct a clinical trial in that country as part of the Phase 3 segment of INOVIO’s global Phase 2/3 trial.
September 22, 2021
·
7 min read
FDA
CARISMA Therapeutics Announces U.S. Food and Drug Administration Grants Fast Track Designation to CT-0508 for the Treatment of Patients with Solid Tumors
CARISMA Therapeutics Inc. announced today that that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CT-0508
September 22, 2021
·
3 min read
FDA
Incyte Announces FDA Approval of Jakafi® (ruxolitinib) for Treatment of Chronic Graft-Versus-Host Disease (GVHD)
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi® (ruxolitinib) for treatment of chronic graft-versus-host disease (GVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.
September 22, 2021
·
11 min read
Genetown
Elicio Therapeutics Presents Updated Preclinical Data at the 2021 Vaccines Summit Demonstrating that ELI-005, a Lymph Node Targeted Amphiphile Vaccine, Induces Potent Cellular and Humoral Immunity to SARS-CoV-2
Elicio Therapeutics, a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases, today announced positive preclinical data demonstrating that ELI-005, a protein subunit vaccine containing the lymph node-targeted Amphiphile-CpG adjuvant (AMP-CpG), induces potent cellular and humoral immunity to SARS-CoV-2 at the 2021 Vaccines Summit.
September 22, 2021
·
7 min read
Alkermes to Take Part in the Cantor Virtual Global Healthcare Conference
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, Sept. 29, 2021 at 8:40 a.m. ET
September 22, 2021
·
1 min read
Genetown
Synlogic Announces Proposed Public Offering of Common Stock - Sep 22, 2021
Synlogic, a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced that it has commenced an underwritten public offering of its common stock.
September 22, 2021
·
3 min read
Biotech Bay
Vaxart To Present at Upcoming Vaccine Conferences
Vaxart, Inc. (NASDAQ: VXRT), today announced that one of the company’s senior scientists, Susan Johnson PhD, will present at both ID Week 2021 and the 15 th Vaccine Congress.
September 22, 2021
·
5 min read
Genetown
Scholar Rock to Present at the 2021 Cantor Virtual Global Healthcare Conference
Scholar Rock today announced that management will present at the 2021 Cantor Virtual Global Healthcare Conference on Wednesday, September 29 th , 2021 at 11:20 a.m. ET.
September 22, 2021
·
1 min read
Previous
19 of 23
Next